These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2507515)

  • 1. The concurrent use of lithium and methylphenidate in a child.
    Licamele WL; Goldberg RL
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):785-7. PubMed ID: 2507515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of methylphenidate and lithium on attention and activity level.
    Carlson GA; Rapport MD; Kelly KL; Pataki CS
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):262-70. PubMed ID: 1564028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate-induced mania in a prepubertal child.
    Koehler-Troy C; Strober M; Malenbaum R
    J Clin Psychiatry; 1986 Nov; 47(11):566-7. PubMed ID: 3771504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.
    Barkley RA; DuPaul GJ; McMurray MB
    Pediatrics; 1991 Apr; 87(4):519-31. PubMed ID: 2011430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts. Psychopharmacology in children.
    Biederman J; Jellinek MS
    N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy of methylphenidate in children and adolescents.
    Klein RG
    Encephale; 1993; 19(2):89-93. PubMed ID: 8275902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 8. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
    Liu C; Robin AL; Brenner S; Eastman J
    Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal brain dysfunction and methylphenidate.
    Schwartz ML; Pizzo SV; McKee PA
    N Engl J Med; 1971 Jul; 285(5):293. PubMed ID: 5090403
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untoward effects of lithium treatment in children aged four through six years.
    Hagino OR; Weller EB; Weller RA; Washing D; Fristad MA; Kontras SB
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1584-90. PubMed ID: 8543529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.
    Pelham WE; Hoza B; Pillow DR; Gnagy EM; Kipp HL; Greiner AR; Waschbusch DA; Trane ST; Greenhouse J; Wolfson L; Fitzpatrick E
    J Consult Clin Psychol; 2002 Apr; 70(2):320-35. PubMed ID: 11952190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities.
    Kaufmann R; Goldberg-Stern H; Shuper A
    J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.